158 related articles for article (PubMed ID: 14792342)
1. The incidence of carcinoma of the prostate in cirrhosis of the liver.
JOHNS VJ; HIRST A
Calif Med; 1950 Dec; 73(6):503-4. PubMed ID: 14792342
[TBL] [Abstract][Full Text] [Related]
2. Varying incidence of cirrhosis and hepatocellular carcinoma in patients with chronic hepatitis C responding differently to interferon therapy.
Shindo M; Ken A; Okuno T
Cancer; 1999 May; 85(9):1943-50. PubMed ID: 10223234
[TBL] [Abstract][Full Text] [Related]
3. [Incidence of hepatocellular carcinoma and consequent lessons for its management in Northeastern Hungary].
Papp R; Papp M; Tornai I; Vitális Z
Orv Hetil; 2016 Nov; 157(45):1793-1801. PubMed ID: 27817236
[TBL] [Abstract][Full Text] [Related]
4. Pathology of liver cirrhosis and hepatocellular carcinoma. Recent studies by Japanese workers.
Mori W; Machinami R
Acta Pathol Jpn; 1982; 32 Suppl 1():133-43. PubMed ID: 6196936
[TBL] [Abstract][Full Text] [Related]
5. Effect of sustained virologic response on the incidence of hepatocellular carcinoma in patients with HCV cirrhosis.
Cheinquer N; Cheinquer H; Wolff FH; Coelho-Borges S
Braz J Infect Dis; 2010; 14(5):457-61. PubMed ID: 21221473
[TBL] [Abstract][Full Text] [Related]
6. Hepatitis B virus, hepatocellular carcinoma and liver cirrhosis in Kenya.
Mwangi J; Gatei DG
East Afr Med J; 1993 Apr; 70(4 Suppl):34-6. PubMed ID: 8223308
[TBL] [Abstract][Full Text] [Related]
7. Hepatocellular carcinoma and cirrhosis: a review of their relative incidence in a 25-year period in the Florence area.
Bartoloni St Omer F; Giannini A; Napoli P
Hepatogastroenterology; 1984 Oct; 31(5):215-7. PubMed ID: 6096240
[TBL] [Abstract][Full Text] [Related]
8. Risk of liver and other types of cancer in patients with cirrhosis: a nationwide cohort study in Denmark.
Sorensen HT; Friis S; Olsen JH; Thulstrup AM; Mellemkjaer L; Linet M; Trichopoulos D; Vilstrup H; Olsen J
Hepatology; 1998 Oct; 28(4):921-5. PubMed ID: 9755226
[TBL] [Abstract][Full Text] [Related]
9. Interferon therapy does not prevent hepatocellular carcinoma in HCV compensated cirrhosis.
Testino G; Ansaldi F; Andorno E; Ravetti GL; Ferro C; De Iaco F; Icardi G; Valente U
Hepatogastroenterology; 2002; 49(48):1636-8. PubMed ID: 12397752
[TBL] [Abstract][Full Text] [Related]
10. The effect of HIV coinfection on the risk of cirrhosis and hepatocellular carcinoma in U.S. veterans with hepatitis C.
Kramer JR; Giordano TP; Souchek J; Richardson P; Hwang LY; El-Serag HB
Am J Gastroenterol; 2005 Jan; 100(1):56-63. PubMed ID: 15654781
[TBL] [Abstract][Full Text] [Related]
11. Non-transplant therapies for patients with hepatocellular carcinoma and Child-Pugh-Turcotte class B cirrhosis.
Granito A; Bolondi L
Lancet Oncol; 2017 Feb; 18(2):e101-e112. PubMed ID: 28214411
[TBL] [Abstract][Full Text] [Related]
12. [Screening of hepatocellular carcinoma in patients with liver cirrhosis].
Pateron D; Ganne N; Beaugrand M
Ann Chir; 1993; 47(3):203-5. PubMed ID: 7687419
[No Abstract] [Full Text] [Related]
13. Serum selenium concentration in patients with liver cirrhosis and hepatocellular carcinoma.
Buljevac M; Romić Z; Vucelić B; Banić M; Krznarić Z; Plesko S
Acta Med Croatica; 1996; 50(1):11-4. PubMed ID: 8776109
[TBL] [Abstract][Full Text] [Related]
14. Bacterial infection in cirrhosis, with and without hepatocellular carcinoma.
Yoshida H; Hamada T; Inuzuka S; Ueno T; Sata M; Tanikawa K
Am J Gastroenterol; 1993 Dec; 88(12):2067-71. PubMed ID: 8249975
[TBL] [Abstract][Full Text] [Related]
15. Oral branched-chain amino acid granules reduce the incidence of hepatocellular carcinoma and improve event-free survival in patients with liver cirrhosis.
Hayaishi S; Chung H; Kudo M; Ishikawa E; Takita M; Ueda T; Kitai S; Inoue T; Yada N; Hagiwara S; Minami Y; Ueshima K
Dig Dis; 2011; 29(3):326-32. PubMed ID: 21829025
[TBL] [Abstract][Full Text] [Related]
16. Clinicomorphological manifestations of primary liver carcinoma (PLC) in liver cirrhosis.
Ferlan-Marolt V; Markovic S
Cancer Detect Prev; 1986; 9(5-6):491-3. PubMed ID: 3022928
[TBL] [Abstract][Full Text] [Related]
17. Incidence and risk factors of hepatocellular carcinoma in patients with primary biliary cirrhosis.
Macaron C; Hanouneh IA; Zein NN
Hepatology; 2010 Dec; 52(6):2239; author reply 2239-40. PubMed ID: 21105115
[No Abstract] [Full Text] [Related]
18. [A clinical study of serum erythropoietin concentrations in patients with liver cirrhosis and hepatocellular carcinomas].
Takezaki E; Murakami S; Kagawa K; Omori H; Nishibayashi H
Gan No Rinsho; 1990 Jan; 36(1):19-22. PubMed ID: 2153846
[TBL] [Abstract][Full Text] [Related]
19. Long-term effect of sustained virological response on hepatocellular carcinoma in patients with hepatitis C in Canada.
Janjua NZ; Chong M; Kuo M; Woods R; Wong J; Yoshida EM; Sherman M; Butt ZA; Samji H; Cook D; Yu A; Alvarez M; Tyndall M; Krajden M
J Hepatol; 2017 Mar; 66(3):504-513. PubMed ID: 27818234
[TBL] [Abstract][Full Text] [Related]
20. Impact of long-term tenofovir disoproxil fumarate on incidence of hepatocellular carcinoma in patients with chronic hepatitis B.
Kim WR; Loomba R; Berg T; Aguilar Schall RE; Yee LJ; Dinh PV; Flaherty JF; Martins EB; Therneau TM; Jacobson I; Fung S; Gurel S; Buti M; Marcellin P
Cancer; 2015 Oct; 121(20):3631-8. PubMed ID: 26177866
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
